← SynDRA
FIRSOCOSTAT
SynDRA canonical compound SYN0038136 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ACACA | ACACB |
|---|
| Mechanism of action | acetyl-CoA carboxylase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ACACA NEGATIVE ALLOSTERIC MODULATOR
- Acetyl-CoA carboxylase negative allosteric modulator
- ACACB NEGATIVE ALLOSTERIC MODULATOR
- acetyl-CoA carboxylase inhibitor
Drug classes
Cross-references
Synonyms
- GS-0976
- Ndi-010976
- GS-ACC
- ND-630
- ND 630
- NDI-010976
- XE10NJQ95M
- firsocostatum
- RefChem:921616
- Firsocostat [USAN]
- Firsocostat (GS-0976)
- Firsocostat(ND-630,GS-0976)
- C28H31N3O8S
- FIRSOCOSTAT [INN]
- Firsocostat (USAN/INN)
- UNII-XE10NJQ95M
- FIRSOCOSTAT [WHO-DD]
- orb1300001
- SCHEMBL14945041
- SCHEMBL29539821
- GTPL10645
- EX-A2586
- EBC-71109
- s8893
- WHO 10738
- AKOS037648731
- CS-6509
- NCGC00601691-01
- AC-31460
- BS-15388
- HY-16901
- ND-630; NDI-010976; Firsocostat
- D11640
- FIRSOCOSTAT ( ND-630; GS-0976; NDI-010976)
- 2-[1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno[2,3-d]pyrimidin-3-yl]-2-methylpropanoic acid
- فيرسوكوستات
- 非索考司他
Look up FIRSOCOSTAT in the interactive SynDRA portal →